CTF1 and cardiac hypertrophy: A recent study indicated that circulating CT-1 correlates with cardiac hypertrophy and vascular damage in hypertensive patients so it could serve as a biomarker of left ventricular hypertrophy and dysfunction in these cases [2,3].